1. Wang Y, Cao P, Alshwmi M, Jiang N, Xiao Z, Jiang F, et al. GPX2 suppression of H2O2 stress regulates cervical cancer metastasis and apoptosis via activation of the β-catenin-WNT pathway. Onco Targets Ther. 2019 Aug 19;12:6639–51.
2. Taniguchi M, Ueda Y, Yagi A, Ikeda S, Endo M, Tomimatsu T, et al. Cervical cancer screening rate differs by HPV vaccination status: an interim analysis. Vaccine. 2019 Jul 26;37(32):4424–6.
3. Morrow MP, Kraynyak KA, Sylvester AJ, Dallas M, Knoblock D, Boyer JD, et al. Clinical and immunologic biomarkers for histologic regression of high-grade cervical dysplasia and clearance of HPV16 and HPV18 after immunotherapy. Clin Cancer Res. 2018 Jan 15;24(2):276–94.
4. Ajiro M, Sakai H, Onogi H, Yamamoto M, Sumi E, Sawada T, et al. CDK9 inhibitor FIT-039 suppresses viral oncogenes E6 and E7 and has a therapeutic effect on HPV-induced neoplasia. Clin Cancer Res. 2018 Sep 15;24(18):4518–28.
5. Romanczuk H, Howley PM. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3159–63.